All Cardiometabolic disease articles
-
NewsYour genes could prune your gut bugs and protect you from disease
Researchers uncover genetic peptides that shape gut bacteria and protect against obesity and diabetes, revealing gut health is influenced by more than just diet and opening doors to personalised treatments.
-
NewsScientists report the first use of CRISPR activation to treat a cardiac disease in mice
Researchers have demonstrated for the first time that CRISPR-based gene activation (CRISPRa) can be used to treat genetic heart disease in vivo. The study paves the way for novel targeted therapies for patients with genetic cardiac disorders.
-
NewsGut microbiome influences proteins that drive aging and disease
Scientists have uncovered new associations between gut microbiome and the aging process. The researchers found that certain microbial characteristics may causally influence proteins in the blood linked to inflammation and heart health.
-
NewsRoutine Helicobacter pylori screening does not significantly reduce upper gastrointestinal bleeding in patients after a heart attack
Routine Helicobacter pylori screening did not significantly reduce the risk of upper gastrointestinal bleeding in patients hospitalised for myocardial infarction (MI), according to new research.
-
NewsConnection among gut fungi, genetics and disease risk in humans identified
A novel genome-wide association study sheds light on the human genetic determinants of the fungal component of the human microbiome and their relation to chronic disease.
-
NewsStudy suggests link between hepatitis B immunity and lower risk of developing diabetes
A research study shows that overall HBV immunity is linked with a 15% lower risk of diabetes, with higher protection in younger people and those with higher immunity shown by higher antibody levels.
-
NewsStudy finds significant health benefits from gut microbes transfer
A cohort of overweight teens who received fecal transfer eight years ago were found to have reduced risk for a series of metabolic changes which can lead to heart disease, stroke and diabetes, compared with the participants who received the placebo.
-
NewsMyocardial infarction may be an infectious disease
A pioneering study has demonstrated for the first time that myocardial infarction may be an infectious disease. This discovery challenges the conventional understanding of the pathogenesis of myocardial infarction and opens new avenues for treatment.
-
NewsKidney fibrosis linked to molecule made by gut bacteria
A molecule made by bacteria in the gut can hitch a ride to the kidneys, where it sets off a chain reaction of inflammation, scarring and fibrosis — a serious complication of diabetes and a leading cause of kidney failure.
-
NewsScientists find a microbial molecule that restores liver and gut health
Researchers have discovered that a natural molecule made by gut bacteria can reverse liver damage and repair the gut lining after aflatoxin exposure. The treatment may offer a new, non-toxic way to prevent and treat non-alcoholic fatty liver disease (NAFLD).
-
NewsInvestigating regional-specific gut microbial distribution: an uncharted territory in disease therapeutics
A new perspective highlights the critical role of region-specific gut microbial distribution across intestinal segments (e.g., duodenum, colon) in regulating host metabolism and immunity, challenging traditional fecal-centric approaches.
-
NewsMicrobiome breakthrough: Gut bacterium may hold key to future treatments for widespread chronic diseases
Scientists have identified a common specific gut bacterial strain that may open the door to a new class of therapeutics. This bacterium produces two proteins that influence the body’s hormonal balance and affect weight, bone density, and blood sugar levels.
-
NewsTrapping gut bacteria’s hidden fuel improves blood sugar and liver health, study shows
Scientists have discovered a surprising new way to improve blood sugar levels and reduce liver damage: by trapping a little-known fuel made by gut bacteria before they wreak havoc on the body. It could open the door to new therapies to treat metabolic diseases.
-
NewsNew research uncovers gut microbe-derived metabolites as potential therapy for obesity-related metabolic disorders
New research reveals that certain gut microbial byproducts may hold promise as a novel therapy for obesity-associated metabolic complications by restoring critical hormone-producing cells in the intestine.
-
NewsBeetroot juice lowers blood pressure in older people by changing oral microbiome
The blood pressure lowering effect of nitrate-rich beetroot juice in older people may be due to specific changes in their oral microbiome, according to the largest study of its kind.
-
NewsHow does infection with respiratory syncytial virus affect the health of older adults?
Adults aged 65 and older hospitalized for RSV in Ontario experienced significantly higher rates of adverse outcomes such as longer length of hospital stay, transfer to intensive care, and 30-day mortality, compared with patients hospitalized with influenza, urinary tract infection, or fracture.
-
NewsA gut microbiota metabolite linked to atherosclerosis could revolutionize diagnosis and treatment
A new study has identified a gut microbiota–derived metabolite, imidazole propionate (ImP), that appears in the blood during the early stages of active atherosclerosis, showing promise as a new diagnostic tool and opening the door to personalized treatment strategies.
-
NewsNighttime pistachio snacking may reshape gut microbiome in prediabetic adults
A new study has determined that nighttime pistachio consumption affects gut bacteria in adults with prediabetes. The potential therapeutic implications of the findings may prove significant for people who are working to improve their metabolic health.
-
NewsTracking microbial rhythms reveals new target for treating metabolic diseases
Researchers harness the benefits of time-restricted feeding on the gut microbiome — with the ultimate goal of developing new therapies for obesity, diabetes and related diseases.
-
NewsStudy indicates that severe forms of COVID-19 infection in children may increase cardiovascular disease risks
Scientists analysed blood samples from 147 children across different COVID-19 conditions and identified significant metabolic disruptions beyond the acute viral infection phase. These alterations affect how the body processes fats (triglycerides and cholesterol) critical to healthy heart structure.